Skip to main content

Table 2 Reproductive endocrine parameters in women with prior menstrual disorders and controls before and after HRT

From: Effects of hormone replacement therapy on glucose and lipid metabolism in peri- and postmenopausal women with a history of menstrual disorders

Variable

Perimenopausal

Postmenopausal

Normal menstruation

(N = 410)

Menstrual disorders

(N = 46)

P valuea

Normal menstruation

(N = 120)

Menstrual disorders

(N = 19)

P valuea

E2 (pmol/L)

 Before HRT

63 (28.46, 139.18)

43.52 (18.35, 110.13)

0.11

43.31 (18.35, 76.81)

38.24 (18.40, 57.49)

0.45

 After HRT

195.95 (121.43, 309.67)

205.50 (129.50,440.70)

0.24

166.60 (90.67, 248.89)

98.92 (45.80, 153.00)

0.05

P valueb

0.000

0.000

 

0.000

0.02

 

 Δ E2† (pmol/L)

118.89 (11.23, 228.34)

164.63 (38.43, 361.75)

0.12

89.13 (27.49, 176.74)

55.61 (0.00, 112.65)

0.19

FSH (IU/L)

 Before HRT

69.50 (51.81, 89.60)

69.30 (55.22, 98.60)

0.37

76.73 ± 28.85

74.22 ± 35.02

0.73

 After HRT

43.00 (27.68, 62.46)

43.64 (23.87, 58.39)

0.82

53.86 ± 27.01

54.93 ± 25.76

0.87

P valueb

0.000

0.000

 

0.000

0.005

 

 Δ FSH† (IU/L)

−23.51(−43.71, −5.51)

−28.00(−45.20, −16.01)

0.19

−22.87 ± 25.45

−19.30 ± 25.95

0.57

LH (IU/L)

 Before HRT

37.74 (28.80, 48.57)

39.17 (29.32, 50.67)

0.54

35.19 (27.99, 45.96)

35.03 (24.38, 43.38)

0.76

 After HRT

29.04 (18.48, 39.66)

30.27 (18.74, 41.85)

0.55

30.59 (20.89, 39.74)

31.90 (17.73, 40.77)

0.94

P valueb

0.000

0.001

 

0.000

0.09

 

 Δ LH† (IU/L)

−9.09 ± 17.11

−8.61 ± 17.05

0.86

−6.86(−12.85, 2.81)

−2.61(−9.73, 4.50)

0.46

  1. Data are expressed as medians (25th percentile, 75th percentiles) or mean ± standard deviation as appropriate. P < 0.05 was considered significant.†Value of the difference between the baseline and follow-up reproductive endocrine parameters (E2, FSH, and LH). aP values are for between-group differences by Mann-Whitney U test or independent samples t-test. bP values are for within-group differences by Wilcoxon signed-rank test or paired-samples t test
  2. Others: E2 estradiol, FSH follicle-stimulating hormone, HRT hormone replacement therapy, LH luteinizing hormone